AfterRaise/Investors/ARCH Venture Partners

Investor

ARCH Venture Partners

Named in 9 funding announcements in 2026: led 5 and joined 4, across 9 companies. Every round below links to the announcement that named them.

Rounds led
5
Rounds joined
4
Capital in rounds led (2 co-led)
$839M
Most recent
9 September 2026

For investors, banks and advisers

Want this delivered, filtered to your mandate?

Every morning: the rounds in your sectors, stages and regions. The investor index as an export. First access to what verified founders say their companies need next, on the founder's terms. Tell us what you are looking for and a person replies with what is available for your desk.

Start with the free Daily

Where it invests

Sectors named in these rounds

Invests alongside

Named on the same announcements

Counted from the announcements only. Appearing on the same round is a fact about the round, not a statement about a relationship.

Rounds led

Where the announcement named ARCH Venture Partners as lead

CompanyRaisedRoundAnnouncedCo-led withSource
Happy Health USA$75MSeries A2026-08-25co-led with OpenLoopannouncement
Oratomic USA$300MSeries A2026-07-07announcement
Trase USA$107MSeed2026-06-26announcement
Ollin Biosciences USA$330MSeries B2026-06-24co-led with TCGXannouncement
Lightcast UK$27MUndisclosed2026-04-15announcement

Rounds joined

Where ARCH Venture Partners participated

CompanyRaisedRoundAnnouncedLed bySource
Encoded Therapeutics USA$275MSeries F2026-09-09led by GV, another healthcare fundannouncement
Moonwalk Biosciences USA$70MSeries B2026-09-08led by Alpha Wave, YK Bioventuresannouncement
LifeMine Therapeutics USA$263MSeries E2026-08-07led by Milky Way Investmentsannouncement
Moleculent Sweden$20MUndisclosed2026-04-30led by Rubicon Healthcare Partnersannouncement

Investor names are read from the funding announcements and grouped by spelling. A round names its investors the way the publisher did; a firm not named in an announcement does not appear here. Corrections: info@afterraise.com.